| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |